skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines tafasitamabQuestion & answer

tafasitamab · Medicine question

What is the terminal elimination half-life of tafasitamab?

iatroX medicinesPublished 8 November 2026

The answer

Answer

The terminal elimination half-life of tafasitamab is 13.4 days.

Sources for this answer

MINJUVI 200 mg powder for concentrate for solution for infusionIncyte Biosciences UK Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 13Document updated 13 October 2026

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

tafasitamab

More questions about tafasitamab

What is the shelf life of an unopened vial of Minjuvi (tafasitamab) 200 mg powder for concentrate for solution for infusion?Can Minjuvi (tafasitamab) affect driving or the use of machines?Can Minjuvi (tafasitamab) be given with other medicines through the same infusion line?Have any incompatibilities been observed between Minjuvi (tafasitamab) and standard infusion materials?Have medicine interaction studies been performed with tafasitamab?Have specific studies evaluated the effects of tafasitamab on fertility?

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the tafasitamab guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX